How much of a priority is treating erectile dysfunction? A study of patients' perceptions

Diabetic Medicine

Volumn 20, Issue 3, 2003, Pages 205-209

  Rance, J ^a   Phillips, C ^b   Davies, S ^b   O'Malley, B ^c   Zaman, Q ^c   Price, David ^d  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c KETTERING GENERAL HOSPITAL   (United Kingdom)

^d MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Diabetes; Erectile dysfunction; Priority; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; BLINDNESS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEPHROPATHY; ERECTILE DYSFUNCTION; HEALTH CARE COST; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMPOTENCE; INDIGESTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PERCEPTION; QUALITY OF LIFE; SLEEP DISORDER;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ATTITUDE TO HEALTH; COST OF ILLNESS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ERECTILE DYSFUNCTION; HEALTH PRIORITIES; HEALTH STATUS; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PERCEPTION; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0037350933     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00903.x     Document Type: Article

References (12)

1. Korenman SG. New insights into erectile dysfunction: a practical approach. Am J Med 1998; 105: 135-144.
2. Price DE, O'Malley BP, Roshan M, James MH, Hearnshaw JR. Why are impotent men not being treated? Pract Diabetes 1991; 8: 10-11.
3. Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 2002; 25: 1458-1463.
4. Price DE. Managing impotence in diabetes. Br Med J 1993; 307: 275-276.
5. Klein R. Puzzling out priorities. Br Med J 1998; 317: 959-960.
6. Plumb JM, Guest JF. Annual cost of erectile dysfunction to UK society. Pharmacoeconomics 1999; 16: 699-709.
7. Lyons RA, Wareham K, Lucas M, Price DE, Williams J, Hutchings HA. SF-36 scores vary by method of administration: implication for study design. J Public Health Med 1999; 21: 41-45.
8. Burchardt M, Burchardt T, Anastasiadis AG, Kiss AJ, Shabsigh A, de La TA et al. Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension. Int J Impot Res 2001; 13: 276-281.
9. Duncan LE, Lewis C, Smith CE, Jenkins P, Nichols M, Pearson TA. Sex, drugs, and hypertension: a methodological approach for studying a sensitive subject. Int J Impot Res 2001; 13: 31-40.
10. Dunn KM, Croft PR, Hackett GI. Sexual problems: a study of the prevalence and need for health care in the general population. Fam Pract 1998; 15: 519-524.
11. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impotence Res 2000; 12: 305-311.
12. Kwok YS, Kim C. Valuing Viagra: what is restoring potency worth? Eff Clin Pract 1999; 2: 171-175.